会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 12. 发明授权
    • NF-AT derived polypeptides that bind calcineurin and uses thereof
    • 结合钙调神经磷酸酶的NF-AT衍生多肽及其用途
    • US06780597B1
    • 2004-08-24
    • US09550115
    • 2000-04-14
    • Ken-ichi AraiJie Liu
    • Ken-ichi AraiJie Liu
    • G01N3353
    • G01N33/6872G01N2500/00
    • Calcineurin (CN)-binding regions in the N-terminal domain derived from NF-ATx is disclosed. Also disclosed are CN-binding polypeptide compositions, DNA segments encoding these polypeptides, and methods of use. The CN-binding polypeptides bind to CN, suppressing the interaction between NF-AT and CN. The CN-binding polypeptide compositions can be used for treating pharmacological intervention with Ca2+-dependent signaling events. The CN-binding polypeptide or DNA segments encoding them can be used to assay and screen candidates of pharmaceuticals, in particular, in the evaluation and characterization of immunosuppressants specifically interfering with the interaction between NF-AT and CN.
    • 公开了衍生自NF-ATx的N-末端结构域中的钙调神经磷酸(CN)结合区。 还公开了CN结合多肽组合物,编码这些多肽的DNA区段和使用方法。 CN结合多肽与CN结合,抑制NF-AT和CN之间的相互作用。 CN结合多肽组合物可用于治疗具有Ca 2+依赖性信号传导事件的药物干预。 CN结合多肽或编码它们的DNA片段可用于测定和筛选药物的候选物,特别是在特异性干扰NF-AT和CN之间的相互作用的免疫抑制剂的评价和表征中。